The global TylosinMarket, by Drug Type (Tylosin Phosphate, Tylosin Tartrate, and Others), byApplication (Felines, Canines, and Livestock), by Route of Administration (Oraland Injectable), and by Region (North America, Latin America, Europe, AsiaPacific, Middle East, and Africa) was valued at US$ 379.0 million in 2017, andis projected to exhibit a CAGR of 1.2% over the forecast period (2018 – 2026).Availability of wide number of therapeutic options, and dosage strengths,antimicrobial efficacy and effectively, high prevalence of infectious diseases,and increasing demand for livestock is expected to fuel growth of the globalTylosin market.
Tylosin is available under brandnames such as Tylan (Tylosin Phosphate) by Elanco, Tylovet (Tylosin Phosphate)by Huvepharma, Tylan Soluble (Tylosin Tartrate) by Elanco, and others. Thedemand for antibiotics for against infection in livestock is on the rise, owingto increasing need for healthy livestock for human consumption. Antibioticssuch as tylosin are used against mycoplasmosis in several animals such aschickens, turkeys, pigs, and calves. Tylosin is administered orally in requireddosage in order to prevent said infections and to grow healthy livestock.Manufacturers such as Elanco Animal Health, Zoetis, Tairui Pharmaceuticals,AdvaCare Pharma, and another offer tylosin in various forms such as activepharmaceutical ingredient and solid dosage form and is generally available inveterinary soluble powder and granule forms.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2061
The U.S. Food & DrugAdministration (FDA) approved new combination uses of Zoetis feed additivesACTOGAIN 45 (ractopamine hydrochloride) and Engain (ractopamine hydrochloride)in 2015. ACTOGAIN 45 can be used with Rumensin (monensin USP) plus Tylovet 100(tylosin phosphate). Browse 17 Market Data Tables and 20 Figures spread through147 Pages and in-depth TOC on Tylosin Market, by Drug Type (Tylosin Phosphate,Tylosin Tartrate, and Others), by Application (Felines, Canines, andLivestock), by Route of Administration (Oral and Injectable), and by Region(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -Global Forecast to 2026
Manufacturers are focused onadopting various strategies such as participation in events and meets, raisingawareness about animal health, and marketing activities in order to showcasetheir products. For instance, Huvepharma participated in Respiratory Health Seminarfor Pig Practitioners that took place in Belgium in 2017. Moreover, the companyheld its 5th European seminar: Insights on Nutrition and Health of HighPerforming Animals in June 2018. Furthermore, in January 2018, Huvepharmaacquired AgriLabs to expand the company’s presence in the U.S. Moreover, in2015, Elanco released an eight-point antibiotic stewardship plan to outlineglobal actions for the company to ensure long-term access to antibiotics forpeople and animals.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/tylosin-market-2061
Key Takeaways of the TylosinMarket:
The global tylosin market isexpected to exhibit a CAGR of 2% over the forecast period (2018 – 2026), owingto various product offering by leading manufacturers
North America and Europe isexpected to retain dominant position in the Tylosin market over the forecastperiod due to presence of leading manufacturers and considerable usage oftylosin in the livestock industry
Major players operating in theglobal tylosin market include, Zoetis, Inc., Tairui Pharmaceuticals, LukangPharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd,Huvepharma, AdvaCare Pharma, and Elanco Animal Health.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2061
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
